Drug Firms Under Suspicion

By The Moscow Times

July 5, 2011

Investigative actions in a number of large pharmaceutical companies in Moscow are part of a criminal investigation into suspected violations of the anti-monopoly legislation, a law enforcement source said.

The case was initiated by the Federal Anti-Monopoly Service on charges of preventing, restricting or removing competition.

"Over 150 contracts totaling more than 66 billion rubles are being checked," the source said. Earlier, police sources reported the confiscation of documents at the Valenta, Akrikhin, Teva and Novartis pharmaceutical firms.

(Interfax)

… we have a small favor to ask.

As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just 2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

Continue